COMMUNIQUÉS West-GlobeNewswire

Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
01/03/2018
REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ) today announced that senior management will present at two upcoming investor healthcare conferences. Management [...]
Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors
01/03/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced the appointment of Mark Klausner [...]
Breathtec Biomedical Announces Appointment of CEO
01/03/2018
VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE:BTH) (CNSX: BTH ) (FRANKFURT: BTI ) (OTCQB:BTHCF) (the “Company”) is pleased to announce the appointment of Christopher J. [...]
Integrated Healthcare Association (IHA) Releases 2nd Edition of the California Regional Health Care Cost & Quality Atlas
01/03/2018
OAKLAND, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Health care quality and cost for commercially insured Californians varied dramatically in 2015, indicating that where you live affects the care you receive and how [...]
Alphatec Holdings to Report Fourth Quarter and Fiscal Year 2017 Financial Results on March 8, 2018
01/03/2018
CARLSBAD, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC ) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that [...]
INSYS Therapeutics Confirms Completion of Founder’s Independent Trust
01/03/2018
PHOENIX, March 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
Helsinn Healthcare S.A.: Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology
01/03/2018
Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology Eleven finalists have been selected from a strong roster of talent to compete at the inaugural Lyfebulb - [...]
Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
01/03/2018
MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
GTX Corp Launches $99.00 Easy Start Plan for GPS SmartSole® and Economy Service Plan as low as $14.95
01/03/2018
LOS ANGELES, March 01, 2018 (GLOBE NEWSWIRE) -- GTX Corp Launches $99.00 Easy Start Plan for GPS SmartSole ® and Economy Service Plan as low as $14.95 3 new pricing models for GPS SmartSole ® and Smart Locator [...]
BriaCell To Present at Precision Breast Cancer Conference
01/03/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Histogenics Corporation to Report 2017 Financial Results on March 15, 2018
01/03/2018
WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, [...]
ChemoCentryx to Hold Fourth Quarter 2017 Financial Results Conference Call on Friday, March 9, 2018
01/03/2018
MOUNTAIN VIEW, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that the Company's fourth quarter 2017 financial results will be released before market open on Friday, [...]
Wildflower Quarterly Revenues Increase to $748,771
01/03/2018
VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the " Company ") is pleased to announce quarterly revenues climbed from $103,893 to $748,771. The Company experienced [...]
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results and Provides Corporate Update
01/03/2018
Cash Balance in excess of $135 million after our February 2018 follow-on financing allows for independent development of lead programs Positive Phase 1/2 Subcutaneous data for CB 2679d presented at EAHAD 2018, Phase 2b [...]
Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease Candidate
01/03/2018
TUSTIN, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
01/03/2018
FIT Biotech Oy Company release March 1, 2018 at 03:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Conformis iTotal CR Knee Replacement System Awarded “3A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
01/03/2018
BILLERICA, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a medical technology company that offers joint replacement implants designed and manufactured to fit and conform to each patient’s [...]
aTyr Pharma to Present at Two Upcoming Investor Conferences in March
01/03/2018
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Iovance Biotherapeutics Appoints Michael Weiser, M.D., Ph.D., to its Board of Directors
01/03/2018
SAN CARLOS, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Pages